D. C. GÜVEN Et Al. , "The burden of polypharmacy and drug-drug interactions in older cancer patients treated with immunotherapy," JOURNAL OF ONCOLOGY PHARMACY PRACTICE , vol.28, no.4, pp.785-793, 2022
GÜVEN, D. C. Et Al. 2022. The burden of polypharmacy and drug-drug interactions in older cancer patients treated with immunotherapy. JOURNAL OF ONCOLOGY PHARMACY PRACTICE , vol.28, no.4 , 785-793.
GÜVEN, D. C., KAVGACI, G., AKTEPE, O. H., YILDIRIM, H. H., ŞAHİN, T. K., AKSOY, S., ... ERMAN, M.(2022). The burden of polypharmacy and drug-drug interactions in older cancer patients treated with immunotherapy. JOURNAL OF ONCOLOGY PHARMACY PRACTICE , vol.28, no.4, 785-793.
GÜVEN, DENİZ Et Al. "The burden of polypharmacy and drug-drug interactions in older cancer patients treated with immunotherapy," JOURNAL OF ONCOLOGY PHARMACY PRACTICE , vol.28, no.4, 785-793, 2022
GÜVEN, DENİZ C. Et Al. "The burden of polypharmacy and drug-drug interactions in older cancer patients treated with immunotherapy." JOURNAL OF ONCOLOGY PHARMACY PRACTICE , vol.28, no.4, pp.785-793, 2022
GÜVEN, D. C. Et Al. (2022) . "The burden of polypharmacy and drug-drug interactions in older cancer patients treated with immunotherapy." JOURNAL OF ONCOLOGY PHARMACY PRACTICE , vol.28, no.4, pp.785-793.
@article{article, author={DENİZ CAN GÜVEN Et Al. }, title={The burden of polypharmacy and drug-drug interactions in older cancer patients treated with immunotherapy}, journal={JOURNAL OF ONCOLOGY PHARMACY PRACTICE}, year=2022, pages={785-793} }